Cargando…
XMRV Discovery and Prostate Cancer-Related Research
Xenotropic murine leukemia virus-related virus (XMRV) was first reported in 2006 in a study of human prostate cancer patients with genetic variants of the antiviral enzyme, RNase L. Subsequent investigations in North America, Europe, Asia, and Africa have either observed or failed to detect XMRV in...
Autores principales: | Kang, David E., Lee, Michael C., Das Gupta, Jaydip, Klein, Eric A., Silverman, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265305/ https://www.ncbi.nlm.nih.gov/pubmed/22312343 http://dx.doi.org/10.1155/2011/432837 |
Ejemplares similares
-
Absence of XMRV and Closely Related Viruses in Primary Prostate Cancer Tissues Used to Derive the XMRV-Infected Cell Line 22Rv1
por: Das Gupta, Jaydip, et al.
Publicado: (2012) -
XMRV replicates preferentially in mucosal sites in vivo: Relevance to XMRV transmission?
por: Villinger, Francois, et al.
Publicado: (2011) -
No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients
por: Mendoza, Ramon, et al.
Publicado: (2012) -
In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer
por: Lee, Deanna, et al.
Publicado: (2012) -
Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies
por: Qiu, Xiaoxing, et al.
Publicado: (2010)